Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CUE
#3645
Cue Biopharma, Inc.
0.2
8
0.00%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
0.00%
Mudança mensal
-26.32%
Mudança em 6 meses
-65.85%
Mudança anual
-76.47%
Fechamento anterior
0.2
8
Open
0.2
8
Bid
Ask
Low
0.2
8
High
0.2
8
Volume
6
Mercados
Ações
Cuidados de saúde
CUE
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
30.46 M
33.01 M
43.17 M
48.64 M
61.82 M
—
Valuation ratios
Enterprise value
306.15 M
308.98 M
71.32 M
90.95 M
44.96 M
170.83 M
Price to earnings ratio
—
—
-1.79
-2.5
-1.51
-5.9
Price to sales ratio
—
—
178.44
18.89
6.09
24.43
Price to cash flow ratio
—
—
-2.27
-3.18
-1.69
-6.49
Price to book ratio
—
—
1.44
3.43
3.51
5.82
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.45
-0.53
-0.58
0.82
1.26
1.29
Return on equity %
-0.57
-0.67
-0.81
1.37
2.32
3.43
Return on invested capital %
-849.98
-804.24
-1 067.99
—
952.32
—
Gross margin %
100
100
100
100
100
400
Operating margin %
-1 427.96
-292.56
-10.02 K
774.3
411.58
3 427.21
EBITDA margin %
—
—
—
—
—
—
Net margin %
-1 419.79
-295.56
-9 975.38
753.27
403.39
3 399.86
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
5.36
5.35
6.68
3.01
1.84
6.13
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.04
0.16
0.01
0.09
0.22
0.22
Solvency ratios
Debt to assets ratio
—
—
0.09
0.07
0
0.02
Debt to equity ratio
—
—
0.12
0.11
0
0.03
Long term debt to total assets ratio
—
—
0.09
0.07
0
0
Long term debt to total equity ratio
—
—
0.12
0.11
0
0
Per share metrics
Operating cash flow per share
—
—
-1.17
0.87
0.64
0.4
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
0.23
0.09
0
0.01
Cash per share
—
—
2.14
1.06
0.4
1.05
Net current asset value per share
—
—
2.17
1.12
0.45
1.24
Tangible book value per share
—
—
1.84
0.81
0.31
0.72
Working capital per share
—
—
1.84
0.75
0.2
0.43
Book value per share
—
—
1.84
0.81
0.31
0.72
Notícias
Cue Biopharma precifica oferta pública de US$ 10 milhões a US$ 0,28 por ação
Cue Biopharma prices $10 million public offering at $0.28 per share
Ações da Cue Biopharma despencam após anúncio de oferta pública
Cue Biopharma stock tumbles on public offering announcement
Cue Biopharma lança oferta pública de ações ordinárias e warrants
Cue Biopharma launches public offering of common stock and warrants
Citizens reitera classificação de Cue Biopharma como Market Outperform
Cue Biopharma stock rating reiterated at Market Outperform by Citizens
ImmunoScape licencia tecnologia da Cue Biopharma para nova terapia contra o câncer
ImmunoScape licenses Cue Biopharma technology for novel cancer therapy
Lucro da Cue Biopharma superou projeções por $0,02; receita menor do que estimativas
Cue Biopharma earnings beat by $0.02, revenue fell short of estimates